All Elizabeth Holmes articles
-
ArticleNeed to know: Elizabeth Holmes’s Theranos trial set to begin
Elizabeth Holmes’s legacy is on the line, as the long-awaited trial of the disgraced founder and CEO of blood-testing company Theranos begins Wednesday.
-
Article
Carreyrou at TPRM: Theranos warning signs were there, but partners failed to spot them
John Carreyrou explained to third-party risk professionals at CW’s TPRM Virtual Summit that the mistakes made by Theranos’s business partners were entirely preventable—had they done their proper due diligence.
-
Article
Elizabeth Holmes might seek ‘mental disease’ defense at Theranos trial
Elizabeth Holmes, founder and CEO of now-defunct blood testing company Theranos, is exploring the idea of using “mental disease or defect” as part of her defense during her criminal fraud trial, which is set to begin in March.
-
Article
John Carreyrou at TPRM: How to spot a wolf in Steve Jobs’ clothing
John Carreyrou, the Wall Street Journal reporter who exposed Theranos and its founder Elizabeth Holmes as frauds, will be the keynote speaker on Day 2 of Compliance Week’s TPRM virtual conference Sept. 18.
-
Blog post
Theranos founder charged in wire fraud scheme
A federal grand jury on June 14 indicted the former founder and chief operating officer of private healthcare and life sciences company, Theranos, arising from allegations that they engaged in a multimillion-dollar scheme to defraud investors, and a separate scheme to defraud doctors and patients.
-
Blog post
Post-mortem on Theranos—where were the controls?
Theranos’s fall from grace is one large-scale compliance failure. The reason? It’s all about internal controls, writes The Man From FCPA.
-
Blog post
Theranos appoints chief compliance officer
Amid a heap of regulatory trouble, start-up life sciences company Theranos announced the appointment of two new executives to lead the company’s regulatory, quality and compliance efforts, including naming a chief compliane officer. The company also created a new compliance and quality committee. Jaclyn Jaeger has the details.
